New Prostate Cancer Test is Ready for Commercialization Following Successful Completion of Final Clinical Trials
Health Discovery Corporation's New Molecular Diagnostic Test for Prostate Cancer Successfully Performs at 90% Sensitivity and 97% Specificity in Double-Blind Clinical Trial
Friday, August 08, 2008
Great News: New Prostate Cancer Test is Ready for Commercialization
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment